Elizabeth Chao

6.0k citations

64 papers · 2.9k indexed · 1 hit paper · h-index 30

Genetics top 1%
- Genomics and Rare Diseases 22
- BRCA gene mutations in cancer 22
- Genomic variations and chromosomal abnormalities 10
Cancer Research top 2%
- Cancer Genomics and Diagnostics 18
Pathology and Forensic Medicine top 2%
- Genetic factors in colorectal cancer 19
Molecular Biology top 10%
- Receptor Mechanisms and Signaling 4
Genetics top 5%
- Genomics and Rare Diseases 22
- BRCA gene mutations in cancer 22
- Genomic variations and chromosomal abnormalities 10
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Endocrinology, Diabetes and Metabolism
- Diabetes Treatment and Management 4

Co-authors: Jill S. Dolinsky Holly LaDuca Tina Pesaran Rachel McFarland Fergus J. Couch David E. Goldgar Hermela Shimelis Erika Palmaer
Cited by: Genetics Cancer Research Pathology and Forensic Medicine
Partner nations: United States Australia Canada

In The Last Decade

Elizabeth Chao

63 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Elizabeth Chao

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Chao more than expected).

Fields of papers citing papers by Elizabeth Chao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Chao. The network helps show where Elizabeth Chao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elizabeth Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Chao Line = papers co-authored together Elizabeth Chao links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Solving Missing Heritability in Patients With Familial Adenomatous Polyposis With DNA-RNA Paired Testing Colin C. Young,Carolyn Horton,Jessica Grzybowski,Nelly Abualkheir,Jesus Ramirez Castano,Bhuvan Molparia,Rachid Karam,Elizabeth Chao,Marcy E. Richardson	2024	3
2	An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance Edwin S. Iversen,Gary Lipton,Steven N. Hart,Kun Y. Lee,Chunling Hu,Eric C. Polley,Tina Pesaran,Amal Yussuf,Holly LaDuca,Elizabeth Chao,Rachid Karam,David E. Goldgar,Fergus J. Couch,Álvaro N.A. Monteiro	2022	4
3	VHL mosaicism: the added value of multi-tissue analysis Leslie E. Oldfield,Jessica Grzybowski,Sylvie Grenier,Elizabeth Chao,Gregory S. Downs,Kirsten M. Farncombe,Tracy Stockley,Özgür Mete,Raymond H. Kim	2022	11
4	Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG) Joshua L. Deignan,Elizabeth Chao,Jennifer Gannon,Henry T. Greely,Kelly D. Farwell Hagman,Rong Mao,Scott Topper	2020	12
5	Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG) Joshua L. Deignan,Wendy K. Chung,Hutton M. Kearney,Kristin G. Monaghan,Catherine Rehder,Elizabeth Chao	2019	121
6	Women with breast and uterine cancer are more likely to harbor germline mutations than women with breast or uterine cancer alone: A case for expanded gene testing Kelly Fulk,Michael R. Milam,Shuwei Li,Amal Yussuf,Mary Helen Black,Elizabeth Chao,Holly LaDuca,Michael P. Stany	2019	11
7	REVEL and BayesDel outperform other in silico meta-predictors for clinical variant classification Yuan Tian,Tina Pesaran,Adam Chamberlin,R. Bryn Fenwick,Shuwei Li,Chia‐Ling Gau,Elizabeth Chao,Hsiao‐Mei Lu,Mary Helen Black,Dajun Qian	2019	58
8	Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models Pengyu Yang,Huafei Zou,Candy Lee,Avinash Muppidi,Elizabeth Chao,Qiangwei Fu,Xiaozhou Luo,Danling Wang,Peter G. Schultz,Weijun Shen	2018	53
9	Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs Avinash Muppidi,Sang Jun Lee,Che‐Hsiung Hsu,Huafei Zou,Candy Lee,Elsa Pflimlin,Madhupriya Mahankali,Pengyu Yang,Elizabeth Chao,Insha Ahmad,Andreas Crameri,Danling Wang,Ashley Woods,Weijun Shen	2018	20
10	Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent Zöe Powis,Carin R. Espenschied,Holly LaDuca,Kelly D. Farwell Hagman,Tripti Paudyal,Shuwei Li,Hiroto Inaba,Ann M. Mauer,Katherine L. Nathanson,James A. Knost,Elizabeth Chao,Sha Tang	2018	3
11	Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization Celeste Eno,Pınar Bayrak‐Toydemir,Lora Jh Bean,Alicia Braxton,Elizabeth Chao,Dima El‐Khechen,Edward D. Esplin,Bethany Friedman,Kelly D. Farwell Hagman,Tina Hambuch,Amy Hernandez,Jane Juusola,Gina Londre,Jerry Machado,Rong Mao,Lindsey Mighion,Heidi L. Rehm,Patricia A. Ward,Joshua L. Deignan	2018	14
12	Clinical laboratories collaborate to resolve differences in variant interpretations submitted to ClinVar Steven M. Harrison,Jill S. Dolinsky,Amy E. Knight Johnson,Tina Pesaran,Danielle R. Azzariti,Sherri J. Bale,Elizabeth Chao,Soma Das,Lisa M. Vincent,Heidi L. Rehm	2017	145
13	Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels Holly LaDuca,Kelly D. Farwell,Huy Gia Vuong,Hsiao‐Mei Lu,Wenbo Mu,Layla Shahmirzadi,Sha Tang,Jefferey Chen,Shruti Bhide,Elizabeth Chao	2017	79
14	Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases Kelly D. Farwell Hagman,Deepali N. Shinde,Cameron Mroske,Erica D. Smith,Kelly Radtke,Layla Shahmirzadi,Dima El‐Khechen,Zöe Powis,Elizabeth Chao,Wendy Alcaraz,Katherine L. Helbig,Samin A. Sajan,Mari Rossi,Hsiao‐Mei Lu,Robert Huether,Shuwei Li,Sitao Wu,Mark E. Nuñes,Sha Tang	2016	34
15	Breast cancer risk is similar for CHEK2 founder and non-founder mutation carriers Tracey P. Leedom,Holly LaDuca,Rachel McFarland,Shuwei Li,Jill S. Dolinsky,Elizabeth Chao	2016	36
16	ClinGen and Genetic Testing. Rachid Karam,Tina Pesaran,Elizabeth Chao	2015	1
17	Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia Felicia Hernandez,Robert Huether,Lester Carter,Tami Johnston,Jennifer Thompson,James R. Gossage,Elizabeth Chao,Aaron Elliott	2015	52
18	Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2 Lindsey E. Minion,Jill S. Dolinsky,Dana M. Chase,Charles Dunlop,Elizabeth Chao,Bradley J. Monk	2015	83
19	Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients Holly LaDuca,Aaron J. Stuenkel,Jill S. Dolinsky,Steven Keiles,Stephany Tandy,Tina Pesaran,Elaine Chen,Chia‐Ling Gau,Erika Palmaer,Kamelia Shoaepour,Divya Shah,Virginia Speare,Stephanie Gandomi,Elizabeth Chao	2014	237
20	Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer Steven M. Lipkin,Elizabeth Chao,Vı́ctor Moreno,Laura S. Rozek,Hedy S. Rennert,Mila Pinchev,Diana Dizon,Gad Rennert,Levy Kopelovich,Stephen B. Gruber	2010	57

About Elizabeth Chao

Elizabeth Chao is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 64 papers that have together received 2.9k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (22 papers), BRCA gene mutations in cancer (22 papers), Genetic factors in colorectal cancer (19 papers), Cancer Genomics and Diagnostics (18 papers), Genomic variations and chromosomal abnormalities (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Diabetes Treatment and Management (4 papers) and Receptor Mechanisms and Signaling (4 papers). The work is most often cited by research in Genetics (1.6k citations), Cancer Research (822 citations) and Pathology and Forensic Medicine (665 citations). Elizabeth Chao has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Jill S. Dolinsky, Holly LaDuca, Tina Pesaran, Rachel McFarland, Fergus J. Couch, David E. Goldgar, Hermela Shimelis, Erika Palmaer, Sha Tang and Robert Huether.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact